Recursion Pharmaceuticals, Inc. (RXRX) · Insider trading
What Recursion Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$8.22M
6 insiders, 100% under a plan
Net, 12 months
−$8.22M
bought less sold
Latest filing
2026-10-07
filings read to 2026-10-20
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Gibson ChristopherDirector | – | $10.35M | 33 | 2026-06-05 | 883,735 |
| Borgeson BlakeDirector | – | $4.50M | 13 | 2026-10-06 | 6,108,287 |
| Khan NajatDirector, CEO and President | – | $1.01M | 5 | 2026-09-08 | 2,072,890 |
| Secora MichaelChief Financial Officer | – | $229,500 | 2 | 2024-11-13 | 1,499,631 |
| Taylor Ben RChief Financial Officer | – | $157,704 | 3 | 2026-03-17 | 1,180,318 |
| Hershberg RobertDirector | – | $125,000 | 1 | 2026-10-06 | 162,156 |
| Marriott TinaPresident and COO | – | $37,860 | 1 | 2024-10-24 | 521,138 |
| Bumpus NamandjeDirector | – | $28,129 | 2 | 2026-06-18 | 127,632 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Hershberg RobertDirector | Saleplan | 25,000 | 5.00 | $125,000 | 162,156 | Form 4 |
| 2026-10-06 | Borgeson BlakeDirector | Saleplan | 50,000 | 4.84 | $242,000 | 6,108,287 | Form 4 |
| 2026-09-08 | Khan NajatDirector, CEO and President | Saleplan | 22,408 | 3.52 | $78,876 | 2,072,890 | Form 4 |
| 2026-09-01 | Borgeson BlakeDirector | Saleplan | 30,000 | 3.34 | $100,200 | 6,158,287 | Form 4 |
| 2026-08-04 | Borgeson BlakeDirector | Saleplan | 30,000 | 3.25 | $97,500 | 6,188,287 | Form 4 |
| 2026-07-07 | Borgeson BlakeDirector | Saleplan | 40,000 | 3.96 | $158,400 | 6,218,287 | Form 4 |
| 2026-06-18 | Bumpus NamandjeDirector | Saleplan | 3,963 | 3.18 | $12,602 | 127,632 | Form 4 |
| 2026-06-05 | Gibson ChristopherDirector | Saleplan | 40,000 | 3.62 | $144,800 | 883,735 | Form 4 |
| 2026-06-05 | Khan NajatDirector, CEO and President | Saleplan | 23,588 | 3.58 | $84,445 | 2,175,796 | Form 4 |
| 2026-06-03 | Bumpus NamandjeDirector | Saleplan | 4,386 | 3.54 | $15,526 | 43,171 | Form 4 |
| 2026-06-02 | Borgeson BlakeDirector | Saleplan | 30,000 | 3.68 | $110,400 | 6,169,863 | Form 4 |
| 2026-05-22 | Gibson ChristopherDirector | Saleplan | 40,000 | 3.08 | $123,200 | 883,735 | Form 4 |
| 2026-05-07 | Gibson ChristopherDirector | Saleplan | 40,000 | 3.37 | $134,800 | 926,556 | Form 4 |
| 2026-05-05 | Borgeson BlakeDirector | Saleplan | 30,000 | 3.52 | $105,600 | 6,199,863 | Form 4 |
| 2026-04-22 | Gibson ChristopherDirector | Saleplan | 40,000 | 3.61 | $144,400 | 906,556 | Form 4 |
| 2026-04-07 | Borgeson BlakeDirector | Saleplan | 30,000 | 3.10 | $93,000 | 6,229,863 | Form 4 |
| 2026-04-07 | Gibson ChristopherDirector | Saleplan | 40,000 | 3.10 | $124,000 | 906,556 | Form 4 |
| 2026-03-23 | Gibson ChristopherDirector | Saleplan | 40,000 | 3.25 | $130,000 | 906,556 | Form 4 |
| 2026-03-17 | Taylor Ben RChief Financial Officer | Saleplan | 7,956 | 3.39 | $26,971 | 1,180,318 | Form 4 |
| 2026-03-09 | Khan NajatDirector, CEO and President | Saleplan | 28,298 | 3.35 | $94,798 | 2,262,085 | Form 4 |
| 2026-03-03 | Borgeson BlakeDirector | Saleplan | 170,000 | 3.46 | $588,200 | 6,259,863 | Form 4 |
| 2026-02-19 | Gibson ChristopherDirector | Saleplan | 40,000 | 3.46 | $138,400 | 906,556 | Form 4 |
| 2026-02-18 | Taylor Ben RChief Financial Officer | Saleplan | 13,426 | 3.08 | $41,352 | 1,195,349 | Form 4 |
| 2026-02-04 | Gibson ChristopherDirector | Saleplan | 40,000 | 4.12 | $164,800 | 913,839 | Form 4 |
| 2026-02-03 | Borgeson BlakeDirector | Saleplan | 220,000 | 4.20 | $924,000 | 6,429,863 | Form 4 |
| 2026-01-20 | Gibson ChristopherDirector | Saleplan | 40,000 | 4.47 | $178,800 | 913,839 | Form 4 |
| 2026-01-06 | Borgeson BlakeDirector | Saleplan | 220,000 | 4.36 | $959,200 | 6,649,863 | Form 4 |
| 2026-01-05 | Gibson ChristopherDirector | Saleplan | 40,000 | 4.25 | $170,000 | 933,839 | Form 4 |
| 2025-12-29 | Taylor Ben RChief Financial Officer | Saleplan | 21,383 | 4.18 | $89,381 | 761,550 | Form 4 |
| 2025-12-22 | Khan NajatDirector, Chief R&D Commercial Officer | Saleplan | 124,403 | 4.41 | $548,617 | 611,135 | Form 4 |
| 2025-12-19 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 40,000 | 4.50 | $180,000 | 913,839 | Form 4 |
| 2025-12-04 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 40,000 | 4.63 | $185,200 | 933,839 | Form 4 |
| 2025-12-02 | Borgeson BlakeDirector | Saleplan | 220,000 | 4.37 | $961,400 | 6,869,863 | Form 4 |
| 2025-11-19 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 40,000 | 4.16 | $166,400 | 913,839 | Form 4 |
| 2025-11-04 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 40,000 | 5.21 | $208,400 | 974,229 | Form 4 |
| 2025-10-23 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 100,000 | 5.70 | $570,000 | 954,229 | Form 4 |
| 2025-10-10 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 100,000 | 6.04 | $604,000 | 974,229 | Form 4 |
| 2025-09-25 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 100,000 | 4.76 | $476,000 | 954,229 | Form 4 |
| 2025-09-10 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 100,000 | 4.71 | $471,000 | 974,229 | Form 4 |
| 2025-08-26 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 100,000 | 4.84 | $484,000 | 954,229 | Form 4 |
20 more
| 2025-08-18 | Khan NajatDirector, Chief R&D Commercial Officer | Sale | 36,599 | 5.52 | $202,026 | 668,197 | Form 4 |
| 2025-08-11 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 500,300 | 5.28 | $2.64M | 1,004,619 | Form 4 |
| 2025-08-11 | Gibson ChristopherDirector, Chief Executive Officer | Saleplanindirect | 100,000 | 5.28 | $528,000 | 0 | Form 4 |
| 2025-08-11 | Gibson ChristopherDirector, Chief Executive Officer | Saleplanindirect | 17,875 | 5.28 | $94,380 | 0 | Form 4 |
| 2025-03-27 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 138,574 | 6.04 | $836,987 | 1,117,450 | Form 4 |
| 2025-03-06 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 6.37 | $127,400 | 1,256,024 | Form 4 |
| 2025-03-05 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 6.58 | $131,600 | 1,256,024 | Form 4 |
| 2025-02-06 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 8.12 | $162,400 | 1,273,156 | Form 4 |
| 2025-02-05 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 7.68 | $153,600 | 1,273,156 | Form 4 |
| 2025-01-10 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 7.05 | $141,000 | 736,633 | Form 4 |
| 2025-01-08 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 7.31 | $146,200 | 736,633 | Form 4 |
| 2024-12-05 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 7.12 | $142,400 | 736,633 | Form 4 |
| 2024-12-04 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 7.16 | $143,200 | 736,633 | Form 4 |
| 2024-11-14 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 7.35 | $147,000 | 762,656 | Form 4 |
| 2024-11-13 | Gibson ChristopherDirector, Chief Executive Officer | Saleplan | 20,000 | 7.74 | $154,800 | 762,656 | Form 4 |
| 2024-11-13 | Secora MichaelChief Financial Officer | Saleplan | 15,000 | 7.66 | $114,900 | 1,499,631 | Form 4 |
| 2024-11-12 | Secora MichaelChief Financial Officer | Saleplan | 15,000 | 7.64 | $114,600 | 1,475,256 | Form 4 |
| 2024-11-12 | Borgeson BlakeDirector | Saleplan | 11,447 | 7.64 | $87,455 | 7,066,113 | Form 4 |
| 2024-10-29 | Borgeson BlakeDirector | Saleplan | 11,447 | 6.72 | $76,924 | 7,077,560 | Form 4 |
| 2024-10-24 | Marriott TinaPresident and COO | Saleplan | 6,000 | 6.31 | $37,860 | 521,138 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
52 × grant or award45 × shares withheld for tax33 × conversion8 × gift4 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-06 | Hershberg RobertDirector | Option exercise M | +25,000 | 2.22 | 187,156 | Form 4 |
| 2026-10-01 | Li Dean YDirector | Grant or award A | +3,378 | – | 1,476,707 | Form 4 |
| 2026-10-01 | Dar ZavainDirector | Grant or award A | +4,607 | – | 245,371 | Form 4 |
| 2026-09-15 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −5,396 | 3.41 | 1,071,462 | Form 4 |
| 2026-08-17 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −25,018 | 3.16 | 1,076,858 | Form 4 |
| 2026-08-17 | Hallett DavidChief Scientific Officer | Shares withheld for tax F | −26,657 | 3.16 | 1,043,837 | Form 4 |
| 2026-08-17 | Khan NajatDirector, CEO and President | Shares withheld for tax F | −80,498 | 3.16 | 2,095,298 | Form 4 |
| 2026-07-01 | Li Dean YDirector | Grant or award A | +3,747 | – | 1,473,329 | Form 4 |
| 2026-07-01 | Dar ZavainDirector | Grant or award A | +5,109 | – | 240,764 | Form 4 |
| 2026-06-17 | Bumpus NamandjeDirector | Grant or award A | +88,424 | – | 131,595 | Form 4 |
| 2026-06-17 | Li Dean YDirector | Grant or award A | +88,424 | – | 1,469,582 | Form 4 |
| 2026-06-17 | Dar ZavainDirector | Grant or award A | +88,424 | – | 235,655 | Form 4 |
| 2026-06-17 | Sun Elaine DDirector | Grant or award A | +88,424 | – | 135,981 | Form 4 |
| 2026-06-17 | Michor FranziskaDirector | Grant or award A | +88,424 | – | 215,477 | Form 4 |
| 2026-06-17 | Hershberg RobertDirector | Grant or award A | +88,424 | – | 162,156 | Form 4 |
| 2026-06-17 | Borgeson BlakeDirector | Grant or award A | +88,424 | – | 6,258,287 | Form 4 |
| 2026-06-15 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −5,396 | 3.15 | 1,101,876 | Form 4 |
| 2026-06-05 | Gibson ChristopherDirector | Conversion C | +40,000 | – | 923,735 | Form 4 |
| 2026-05-22 | Gibson ChristopherDirector | Conversion C | +40,000 | – | 923,735 | Form 4 |
| 2026-05-15 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −25,018 | 3.04 | 1,107,272 | Form 4 |
| 2026-05-15 | Gibson ChristopherDirector | Shares withheld for tax F | −22,821 | 3.04 | 883,735 | Form 4 |
| 2026-05-15 | Hallett DavidChief Scientific Officer | Shares withheld for tax F | −26,657 | 3.04 | 1,070,494 | Form 4 |
| 2026-05-15 | Khan NajatDirector, CEO and President | Shares withheld for tax F | −62,701 | 3.04 | 2,199,384 | Form 4 |
| 2026-05-07 | Gibson ChristopherDirector | Conversion C | +60,000 | – | 966,556 | Form 4 |
| 2026-05-07 | Gibson ChristopherDirector | Gift G | −20,000 | – | 906,556 | Form 4 |
| 2026-04-22 | Gibson ChristopherDirector | Conversion C | +40,000 | – | 946,556 | Form 4 |
| 2026-04-07 | Gibson ChristopherDirector | Conversion C | +40,000 | – | 946,556 | Form 4 |
| 2026-04-06 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −48,028 | 3.11 | 1,132,290 | Form 4 |
| 2026-04-01 | Li Dean YDirector | Grant or award A | +3,268 | – | 1,244,177 | Form 4 |
| 2026-04-01 | Dar ZavainDirector | Grant or award A | +4,902 | – | 147,231 | Form 4 |
| 2026-03-23 | Gibson ChristopherDirector | Conversion C | +40,000 | – | 946,556 | Form 4 |
| 2026-03-16 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −7,075 | 3.42 | 1,188,274 | Form 4 |
| 2026-03-09 | Gibson ChristopherDirector | Conversion C | +20,000 | – | 926,556 | Form 4 |
| 2026-03-09 | Gibson ChristopherDirector | Gift G | −20,000 | – | 906,556 | Form 4 |
| 2026-02-19 | Gibson ChristopherDirector | Conversion C | +40,000 | – | 946,556 | Form 4 |
| 2026-02-17 | Khan NajatDirector, CEO and President | Shares withheld for tax F | −14,280 | 3.49 | 2,290,383 | Form 4 |
| 2026-02-17 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −11,908 | 3.49 | 1,208,775 | Form 4 |
| 2026-02-17 | Gibson ChristopherDirector | Shares withheld for tax F | −27,265 | 3.49 | 906,556 | Form 4 |
| 2026-02-17 | Hallett DavidChief Scientific Officer | Shares withheld for tax F | −11,908 | 3.49 | 1,097,151 | Form 4 |
| 2026-02-06 | Hallett DavidChief Scientific Officer | Grant or award A | +502,064 | – | 1,096,205 | Form 4 |
| 2026-02-06 | Hallett DavidChief Scientific Officer | Grant or award A | +24,254 | – | 1,120,459 | Form 4 |
| 2026-02-06 | Hallett DavidChief Scientific Officer | Shares withheld for tax F | −11,400 | 3.98 | 1,109,059 | Form 4 |
| 2026-02-06 | Taylor Ben RChief Financial Officer | Grant or award A | +446,279 | – | 1,207,829 | Form 4 |
| 2026-02-06 | Taylor Ben RChief Financial Officer | Grant or award A | +24,254 | – | 1,232,083 | Form 4 |
| 2026-02-06 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −11,400 | 3.98 | 1,220,683 | Form 4 |
| 2026-02-06 | Khan NajatDirector, CEO and President | Grant or award A | +1,673,546 | – | 2,284,681 | Form 4 |
| 2026-02-06 | Khan NajatDirector, CEO and President | Grant or award A | +30,346 | – | 2,315,027 | Form 4 |
| 2026-02-06 | Khan NajatDirector, CEO and President | Shares withheld for tax F | −10,364 | 3.98 | 2,304,663 | Form 4 |
| 2026-02-06 | Gibson ChristopherDirector | Grant or award A | +30,346 | – | 944,185 | Form 4 |
| 2026-02-06 | Gibson ChristopherDirector | Shares withheld for tax F | −10,364 | 3.56 | 933,821 | Form 4 |
| 2026-02-04 | Gibson ChristopherDirector | Conversion C | +40,000 | – | 953,839 | Form 4 |
| 2026-01-20 | Gibson ChristopherDirector | Conversion C | +40,000 | – | 953,839 | Form 4 |
| 2026-01-05 | Gibson ChristopherDirector | Conversion C | +60,000 | – | 973,839 | Form 4 |
| 2026-01-05 | Gibson ChristopherDirector | Gift G | −20,000 | – | 913,839 | Form 4 |
| 2026-01-02 | Li Dean YDirector | Grant or award A | +2,381 | – | 1,240,909 | Form 4 |
| 2026-01-02 | Dar ZavainDirector | Grant or award A | +3,571 | – | 142,329 | Form 4 |
| 2025-12-19 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +40,000 | – | 953,839 | Form 4 |
| 2025-12-15 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −7,057 | 4.33 | 782,933 | Form 4 |
| 2025-12-04 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +60,000 | – | 973,839 | Form 4 |
| 2025-12-04 | Gibson ChristopherDirector, Chief Executive Officer | Gift G | −20,000 | – | 913,839 | Form 4 |
| 2025-11-25 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −2,271 | 4.03 | 789,990 | Form 4 |
| 2025-11-19 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +40,000 | – | 953,839 | Form 4 |
| 2025-11-17 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −11,908 | 4.14 | 792,261 | Form 4 |
| 2025-11-17 | Gibson ChristopherDirector, Chief Executive Officer | Shares withheld for tax F | −40,390 | 4.14 | 913,839 | Form 4 |
| 2025-11-17 | Khan NajatDirector, Chief R&D Commercial Officer | Shares withheld for tax F | −17,584 | 4.14 | 735,538 | Form 4 |
| 2025-11-05 | Khan NajatDirector, Chief R&D Commercial Officer | Grant or award A | +84,925 | – | 753,122 | Form 4 |
| 2025-11-04 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +60,000 | – | 1,014,229 | Form 4 |
| 2025-11-04 | Gibson ChristopherDirector, Chief Executive Officer | Gift G | −20,000 | – | 954,229 | Form 4 |
| 2025-10-23 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +100,000 | – | 1,054,229 | Form 4 |
| 2025-10-10 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +120,000 | – | 1,074,229 | Form 4 |
| 2025-10-10 | Gibson ChristopherDirector, Chief Executive Officer | Gift G | −20,000 | – | 954,229 | Form 4 |
| 2025-10-01 | Li Dean YDirector | Grant or award A | +1,961 | – | 1,238,528 | Form 4 |
| 2025-10-01 | Dar ZavainDirector | Grant or award A | +2,941 | – | 138,758 | Form 4 |
| 2025-09-25 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +100,000 | – | 1,054,229 | Form 4 |
| 2025-09-15 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −7,057 | 4.83 | 804,169 | Form 4 |
| 2025-09-10 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +120,000 | – | 1,074,229 | Form 4 |
| 2025-09-10 | Gibson ChristopherDirector, Chief Executive Officer | Gift G | −20,000 | – | 954,229 | Form 4 |
| 2025-08-26 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +100,000 | – | 1,054,229 | Form 4 |
| 2025-08-15 | Khan NajatDirector, Chief R&D Commercial Officer | Shares withheld for tax F | −3,789 | 5.64 | 704,796 | Form 4 |
| 2025-08-15 | Gibson ChristopherDirector, Chief Executive Officer | Shares withheld for tax F | −40,390 | 5.64 | 954,229 | Form 4 |
| 2025-08-15 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −11,908 | 5.64 | 811,226 | Form 4 |
| 2025-08-11 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +423,666 | – | 1,504,919 | Form 4 |
| 2025-08-11 | Gibson ChristopherDirector, Chief Executive Officer | Gift G | −10,000 | – | 994,619 | Form 4 |
| 2025-08-11 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +100,000 | – | 100,000 | Form 4 |
| 2025-08-11 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +17,875 | – | 17,875 | Form 4 |
| 2025-07-01 | Dar ZavainDirector | Grant or award A | +2,924 | – | 135,817 | Form 4 |
| 2025-07-01 | Li Dean YDirector | Grant or award A | +1,949 | – | 1,236,567 | Form 4 |
| 2025-06-18 | Sun Elaine DDirector | Grant or award A | +11,008 | – | 47,557 | Form 4 |
| 2025-06-18 | Li Dean YDirector | Grant or award A | +22,016 | – | 1,234,618 | Form 4 |
| 2025-06-18 | Bumpus NamandjeDirector | Grant or award A | +11,008 | – | 47,557 | Form 4 |
| 2025-06-18 | Dar ZavainDirector | Grant or award A | +22,016 | – | 132,893 | Form 4 |
| 2025-06-18 | Hershberg RobertDirector | Grant or award A | +22,016 | – | 73,732 | Form 4 |
| 2025-06-18 | Michor FranziskaDirector | Grant or award A | +22,016 | – | 127,053 | Form 4 |
| 2025-06-18 | Borgeson BlakeDirector | Grant or award A | +22,016 | – | 7,089,863 | Form 4 |
| 2025-06-16 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −7,057 | 4.92 | 823,134 | Form 4 |
| 2025-05-15 | Gibson ChristopherDirector, Chief Executive Officer | Shares withheld for tax F | −36,197 | 4.25 | 1,081,253 | Form 4 |
| 2025-05-15 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −11,908 | 4.25 | 830,191 | Form 4 |
| 2025-05-15 | Khan NajatDirector, Chief R&D Commercial Officer | Shares withheld for tax F | −3,796 | 4.25 | 708,585 | Form 4 |
| 2025-04-01 | Dar ZavainDirector | Grant or award A | +2,745 | – | 110,877 | Form 4 |
| 2025-04-01 | Li Dean YDirector | Grant or award A | +2,268 | – | 79,618 | Form 4 |
| 2025-04-01 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −26,571 | 5.10 | 842,099 | Form 4 |
| 2025-03-17 | Sun Elaine DDirector | Grant or award A | +36,549 | – | 36,549 | Form 4 |
| 2025-03-17 | Bumpus NamandjeDirector | Grant or award A | +36,549 | – | 36,549 | Form 4 |
| 2025-03-17 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −7,057 | 6.84 | 868,670 | Form 4 |
| 2025-03-06 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 1,276,024 | Form 4 |
| 2025-03-05 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 1,276,024 | Form 4 |
| 2025-02-18 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −10,879 | 10.64 | 875,727 | Form 4 |
| 2025-02-18 | Gibson ChristopherDirector, Chief Executive Officer | Shares withheld for tax F | −17,132 | 10.64 | 1,256,024 | Form 4 |
| 2025-02-06 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 1,293,156 | Form 4 |
| 2025-02-05 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 1,293,156 | Form 4 |
| 2025-02-03 | Gibson ChristopherDirector, Chief Executive Officer | Grant or award A | +525,283 | – | 1,261,916 | Form 4 |
| 2025-02-03 | Gibson ChristopherDirector, Chief Executive Officer | Grant or award A | +16,809 | – | 1,278,725 | Form 4 |
| 2025-02-03 | Gibson ChristopherDirector, Chief Executive Officer | Shares withheld for tax F | −5,569 | 7.25 | 1,273,156 | Form 4 |
| 2025-02-03 | Khan NajatDirector, Chief R&D Commercial Officer | Grant or award A | +210,113 | – | 707,085 | Form 4 |
| 2025-02-03 | Khan NajatDirector, Chief R&D Commercial Officer | Grant or award A | +8,049 | – | 715,134 | Form 4 |
| 2025-02-03 | Khan NajatDirector, Chief R&D Commercial Officer | Shares withheld for tax F | −2,753 | 7.25 | 712,381 | Form 4 |
| 2025-02-03 | Taylor Ben RChief Financial Officer | Grant or award A | +35,018 | – | 879,228 | Form 4 |
| 2025-02-03 | Taylor Ben RChief Financial Officer | Grant or award A | +13,922 | – | 893,150 | Form 4 |
| 2025-02-03 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −6,544 | 7.25 | 886,606 | Form 4 |
| 2025-01-10 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 756,633 | Form 4 |
| 2025-01-08 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 756,633 | Form 4 |
| 2025-01-02 | Borgeson BlakeDirector | Grant or award A | +1,734 | – | 7,067,847 | Form 4 |
| 2025-01-02 | Li Dean YDirector | Grant or award A | +1,647 | – | 77,350 | Form 4 |
| 2025-01-02 | Dar ZavainDirector | Grant or award A | +1,907 | – | 108,132 | Form 4 |
| 2024-12-19 | Taylor Ben RChief Financial Officer | Grant or award A | +370,343 | – | 844,210 | Form 4 |
| 2024-12-17 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −7,057 | 6.95 | 473,867 | Form 4 |
| 2024-12-16 | Taylor Ben RChief Financial Officer | Shares withheld for tax F | −15,668 | 6.04 | 480,924 | Form 4 |
| 2024-12-05 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 756,633 | Form 4 |
| 2024-12-04 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 756,633 | Form 4 |
| 2024-11-20 | Michor FranziskaDirector | Grant or award A | +30,618 | – | 30,618 | Form 4 |
| 2024-11-20 | Michor FranziskaDirector | Grant or award A | +15,335 | – | 45,953 | Form 4 |
| 2024-11-20 | Michor FranziskaDirector | Grant or award A | +17,694 | – | 63,647 | Form 4 |
| 2024-11-20 | Michor FranziskaDirector | Grant or award A | +41,390 | – | 105,037 | Form 4 |
| 2024-11-15 | Gibson ChristopherDirector, Chief Executive Officer | Shares withheld for tax F | −26,023 | 6.18 | 736,633 | Form 4 |
| 2024-11-15 | Marriott TinaPresident and COO | Shares withheld for tax F | −14,286 | 6.18 | 506,852 | Form 4 |
| 2024-11-15 | Secora MichaelChief Financial Officer | Shares withheld for tax F | −11,937 | 6.18 | 1,487,694 | Form 4 |
| 2024-11-15 | Mauro David JChief Medical Officer | Shares withheld for tax F | −4,187 | 6.18 | 225,429 | Form 4 |
| 2024-11-14 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 782,656 | Form 4 |
| 2024-11-13 | Gibson ChristopherDirector, Chief Executive Officer | Conversion C | +20,000 | – | 782,656 | Form 4 |
| 2024-11-13 | Secora MichaelChief Financial Officer | Option exercise M | +39,375 | 2.22 | 1,514,631 | Form 4 |
| 2024-11-12 | Secora MichaelChief Financial Officer | Option exercise M | +39,375 | 2.22 | 1,490,256 | Form 4 |
| 2024-10-24 | Marriott TinaPresident and COO | Option exercise M | +6,000 | 1.06 | 527,138 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.